DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydroxyurea (Hydroxyurea) - Neoplasm Malignant - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neoplasm Malignant (29)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydroxyurea where reactions include neoplasm malignant. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydroxyurea side effects in

Reported by a consumer/non-health professional from United States on 2012-06-19

Patient:

Reactions: Myelofibrosis, Pharyngeal Disorder, Neoplasm Malignant, Mouth Ulceration, Thrombocytosis, Blood Disorder, Oropharyngeal Blistering, Skin Reaction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Anagrelide HCL
    Dosage: 0.5 mg, qd
    Indication: Essential Thrombocythaemia
    Start date: 2009-12-01
    End date: 2010-01-26

Hydroxyurea
    Dosage: 750 mg, qd
    Start date: 1994-04-22
    End date: 2008-06-12

Hydroxyurea
    Dosage: 714 mg, qd
    Indication: Essential Thrombocythaemia
    Start date: 2008-06-12
    End date: 2010-01-26

Hydroxyurea
    Dosage: 857 mg, qd
    Start date: 2010-01-26

Clopidogrel
    Dosage: 75 mg, qd
    Indication: Essential Thrombocythaemia
    Start date: 2010-01-23
    End date: 2010-06-15

Aspirin
    Dosage: 75 mg, qd
    Start date: 2007-04-06
    End date: 2010-03-23

Aspirin
    Dosage: 75 mg, qd
    Start date: 2010-05-10

Other drugs received by patient: Allopurinol



Possible Hydroxyurea side effects in 68 year old male

Reported by a consumer/non-health professional from Germany on 2012-04-13

Patient: 68 year old male

Reactions: Neoplasm Malignant, Cardiac Failure, Major Depression, Penis Carcinoma, Spinal Osteoarthritis, Leukocytosis, Haemorrhoidal Haemorrhage

Drug(s) suspected as cause:
Hydroxyurea
    Indication: Chronic Myeloid Leukaemia
    Start date: 2002-01-01
    End date: 2011-01-01

Nilotinib
    Start date: 2008-01-01

Thioguanine
    Start date: 2009-01-01
    End date: 2011-01-01

Imatinib Mesylate
    Dosage: also received in 2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2004-01-01



Possible Hydroxyurea side effects in 68 year old male

Reported by a physician from Germany on 2012-04-04

Patient: 68 year old male

Reactions: Cardiac Failure, Neoplasm Malignant, Major Depression, Spinal Osteoarthritis, Penis Carcinoma, Leukocytosis, Haemorrhoidal Haemorrhage

Drug(s) suspected as cause:
Thioguanine
    Start date: 2009-01-01
    End date: 2011-01-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia
    Start date: 2002-01-01
    End date: 2011-01-01

Imatinib Mesylate
    Dosage: also received in 2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2004-01-01

Nilotinib
    Start date: 2008-01-01



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-04-02

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 57 year old male

Reported by a physician from Germany on 2012-03-27

Patient: 57 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Disorder, Pneumonia, Cholestasis, Transaminases Increased, Pericardial Effusion, Neoplasm Malignant, Pleural Effusion, Thrombocytopenia, Pneumonitis, Leukopenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: 5 days
    Start date: 2009-09-02

Interferon Alfa
    Dosage: 1df= 1.0 million;08dec2009-dec2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2009-12-08
    End date: 2010-06-01

Sprycel
    Dosage: paused since 03jan2011 and discontinued on 18jan2011
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    End date: 2011-01-18

Imatinib Mesylate
    Dosage: 15sep2009-dec2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2009-09-15



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-03-25

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-23

Patient: 62 year old male

Reactions: Neoplasm Malignant, Lung Neoplasm Malignant

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 53 year old male

Reactions: Neoplasm Malignant, Carcinoid Tumour of THE Small Bowel

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 65 year old female

Reactions: Myelofibrosis, Neoplasm Malignant

Drug(s) suspected as cause:
Nilotinib
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 49 year old female

Reactions: Breast Cancer, Neoplasm Malignant

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 69 year old male

Reactions: Neoplasm Malignant, Gastric Cancer

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 52 year old male

Reactions: Neoplasm Malignant, Prostate Cancer

Drug(s) suspected as cause:
Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 55 year old male

Reactions: Colon Cancer, Neoplasm Malignant

Drug(s) suspected as cause:
Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Indication: Chronic Myeloid Leukaemia

Nilotinib
    Indication: Chronic Myeloid Leukaemia

Interferon
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 68 year old female

Reactions: Phaeochromocytoma, Neoplasm Malignant

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20

Patient: 43 year old male

Reactions: Neoplasm Malignant, Anal Cancer

Drug(s) suspected as cause:
Imatinib Mesylate
    Indication: Chronic Myeloid Leukaemia

Busulfan
    Indication: Chronic Myeloid Leukaemia

Interferon
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19

Patient: 71 year old male

Reactions: Chronic Lymphocytic Leukaemia, Neoplasm Malignant

Drug(s) suspected as cause:
Interferon
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19

Patient: 63 year old male

Reactions: Prostate Cancer, Neoplasm Malignant

Drug(s) suspected as cause:
Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Cytarabine
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19

Patient: 32 year old female

Reactions: Neoplasm Malignant, Cervix Carcinoma Stage 0

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 41 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 41 year old male

Reactions: Colon Cancer, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Cytarabine
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 62 year old female

Reactions: Neoplasm Malignant, Lung Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 68 year old male

Reactions: Lung Adenocarcinoma, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 46 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 46 year old male

Reactions: Lung Adenocarcinoma, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 36 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 36 year old male

Reactions: Seminoma, Neoplasm Malignant, Chronic Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Busulfan
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 71 year old male

Reactions: Laryngeal Cancer, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 74 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 74 year old male

Reactions: Malignant Neoplasm of Ampulla of Vater, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Other drugs received by patient: Cytarabine



Possible Hydroxyurea side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 59 year old male

Reactions: Death, Neoplasm Malignant, Malignant Melanoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Other drugs received by patient: Interferon



Possible Hydroxyurea side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 68 year old male

Reactions: Neoplasm Malignant, Lung Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Interferon
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 73 year old female

Reactions: Adenocarcinoma Pancreas, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18

Patient: 72 year old female

Reactions: Uterine Cancer, Death, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: unk ukn, unk
    Indication: Chronic Myeloid Leukaemia

Hydroxyurea
    Dosage: unk
    Indication: Chronic Myeloid Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017